Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01431794
Title Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

pancreatic adenocarcinoma

Therapies

Gemcitabine + Nab-paclitaxel + Sonidegib

Age Groups: adult
Covered Countries USA


No variant requirements are available.